Natural Biocon sets September 5 board meeting for AGM approvals
- Board meeting scheduled for September 5, 2026
- Agenda includes ratification of EGM resolutions from May 2024
- Approval of Director’s and Secretarial Audit Reports for FY26
- Fixing of AGM date, venue, and book closure dates

*this image is generated using AI for illustrative purposes only.
Natural Biocon has scheduled a Board of Directors meeting for September 5, 2026. The session will focus on approving the Annual General Meeting (AGM) logistics and statutory reports for the fiscal year ended March 31, 2026.
The company issued the intimation pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is set to take place at the company’s registered office in Ahmedabad.
Agenda Items
The board will consider and approve several key resolutions during the session. The primary agenda includes:
- Ratification of resolutions passed at the Extraordinary General Meeting held on May 23, 2024.
- Approval of the draft Director’s Report and Secretarial Audit Report for the year ended March 31, 2026.
- Fixing the date, time, and venue for the Annual General Meeting.
- Deciding on dates for the closure of the Register of Members and Share Transfer Register for the annual book closure.
- Approving the draft notice for the AGM.
- Appointing a scrutinizer for remote e-voting and voting at the AGM.
Arunkumar Prajapati, Managing Director, signed the communication addressed to the General Manager of the Corporation Relationship Department at BSE Limited.
Historical Stock Returns for Natural Biocon
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.10% | +2.28% | -16.90% | -14.52% | -54.33% | -85.52% |
What specific strategic initiatives or financial targets will be highlighted in the Director's Report for the fiscal year ended March 31, 2026?
How might the ratification of resolutions from the May 2024 Extraordinary General Meeting impact Natural Biocon's capital structure or operational governance?
Will the Secretarial Audit Report reveal any compliance discrepancies or governance improvements that could influence investor confidence?

































